Click for best price
Insomnia Therapeutics Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 2755.6 million
|
Forecast Market size by 2030 |
US$ 3534 million
|
| Growth Rate |
CAGR of 3.6% |
Number of Pages |
108 Pages |
This research report provides a comprehensive analysis of the Insomnia Therapeutics Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Insomnia Therapeutics Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Insomnia Therapeutics Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Insomnia Therapeutics Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Insomnia Therapeutics Drugs market presents opportunities for various stakeholders, including Prescription, Over-the-Counter (OTC). Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Insomnia Therapeutics Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Insomnia Therapeutics Drugs market was valued at US$ 2755.6 million in 2023 and is projected to reach US$ 3534 million by 2030, at a CAGR of 3.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Insomnia Therapeutics Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Insomnia Therapeutics Drugs market.
Market Overview: The report provides a comprehensive overview of the Insomnia Therapeutics Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Benzodiazepines, Nonbenzodiazepines), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Insomnia Therapeutics Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Insomnia Therapeutics Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Insomnia Therapeutics Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Insomnia Therapeutics Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Insomnia Therapeutics Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Insomnia Therapeutics Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Insomnia Therapeutics Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Insomnia Therapeutics Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Insomnia Therapeutics Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Others
Market segment by Application
Prescription
Over-the-Counter (OTC)
Global Insomnia Therapeutics Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Takeda Pharmaceutical Company Ltd.
Vanda Pharmaceuticals
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sumitomo Dainippon Pharma Co., Ltd
Sanofi
Paratek Pharmaceuticals Inc.
Ebb Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Insomnia Therapeutics Drugs, market overview.
Chapter 2: Global Insomnia Therapeutics Drugs market size in revenue.
Chapter 3: Detailed analysis of Insomnia Therapeutics Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Insomnia Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Insomnia Therapeutics Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 2755.6 million
|
| Forecast Market size by 2030 |
US$ 3534 million
|
| Growth Rate |
CAGR of 3.6% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
108 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Insomnia Therapeutics Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insomnia Therapeutics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insomnia Therapeutics Drugs Overall Market Size
2.1 Global Insomnia Therapeutics Drugs Market Size: 2023 VS 2030
2.2 Global Insomnia Therapeutics Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Insomnia Therapeutics Drugs Players in Global Market
3.2 Top Global Insomnia Therapeutics Drugs Companies Ranked by Revenue
3.3 Global Insomnia Therapeutics Drugs Revenue by Companies
3.4 Top 3 and Top 5 Insomnia Therapeutics Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Insomnia Therapeutics Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Insomnia Therapeutics Drugs Players in Global Market
3.6.1 List of Global Tier 1 Insomnia Therapeutics Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Insomnia Therapeutics Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Insomnia Therapeutics Drugs Market Size Markets, 2023 & 2030
4.1.2 Benzodiazepines
4.1.3 Nonbenzodiazepines
4.1.4 Antidepressants
4.1.5 Orexin Antagonists
4.1.6 Melatonin Antagonists
4.1.7 Others
4.2 By Type - Global Insomnia Therapeutics Drugs Revenue & Forecasts
4.2.1 By Type - Global Insomnia Therapeutics Drugs Revenue, 2019-2024
4.2.2 By Type - Global Insomnia Therapeutics Drugs Revenue, 2025-2030
4.2.3 By Type - Global Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insomnia Therapeutics Drugs Market Size, 2023 & 2030
5.1.2 Prescription
5.1.3 Over-the-Counter (OTC)
5.2 By Application - Global Insomnia Therapeutics Drugs Revenue & Forecasts
5.2.1 By Application - Global Insomnia Therapeutics Drugs Revenue, 2019-2024
5.2.2 By Application - Global Insomnia Therapeutics Drugs Revenue, 2025-2030
5.2.3 By Application - Global Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Insomnia Therapeutics Drugs Market Size, 2023 & 2030
6.2 By Region - Global Insomnia Therapeutics Drugs Revenue & Forecasts
6.2.1 By Region - Global Insomnia Therapeutics Drugs Revenue, 2019-2024
6.2.2 By Region - Global Insomnia Therapeutics Drugs Revenue, 2025-2030
6.2.3 By Region - Global Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Insomnia Therapeutics Drugs Revenue, 2019-2030
6.3.2 US Insomnia Therapeutics Drugs Market Size, 2019-2030
6.3.3 Canada Insomnia Therapeutics Drugs Market Size, 2019-2030
6.3.4 Mexico Insomnia Therapeutics Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Insomnia Therapeutics Drugs Revenue, 2019-2030
6.4.2 Germany Insomnia Therapeutics Drugs Market Size, 2019-2030
6.4.3 France Insomnia Therapeutics Drugs Market Size, 2019-2030
6.4.4 U.K. Insomnia Therapeutics Drugs Market Size, 2019-2030
6.4.5 Italy Insomnia Therapeutics Drugs Market Size, 2019-2030
6.4.6 Russia Insomnia Therapeutics Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Insomnia Therapeutics Drugs Market Size, 2019-2030
6.4.8 Benelux Insomnia Therapeutics Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Insomnia Therapeutics Drugs Revenue, 2019-2030
6.5.2 China Insomnia Therapeutics Drugs Market Size, 2019-2030
6.5.3 Japan Insomnia Therapeutics Drugs Market Size, 2019-2030
6.5.4 South Korea Insomnia Therapeutics Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Insomnia Therapeutics Drugs Market Size, 2019-2030
6.5.6 India Insomnia Therapeutics Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Insomnia Therapeutics Drugs Revenue, 2019-2030
6.6.2 Brazil Insomnia Therapeutics Drugs Market Size, 2019-2030
6.6.3 Argentina Insomnia Therapeutics Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Insomnia Therapeutics Drugs Revenue, 2019-2030
6.7.2 Turkey Insomnia Therapeutics Drugs Market Size, 2019-2030
6.7.3 Israel Insomnia Therapeutics Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Insomnia Therapeutics Drugs Market Size, 2019-2030
6.7.5 UAE Insomnia Therapeutics Drugs Market Size, 2019-2030
7 Insomnia Therapeutics Drugs Companies Profiles
7.1 Takeda Pharmaceutical Company Ltd.
7.1.1 Takeda Pharmaceutical Company Ltd. Company Summary
7.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
7.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Major Product Offerings
7.1.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue in Global Market (2019-2024)
7.1.5 Takeda Pharmaceutical Company Ltd. Key News & Latest Developments
7.2 Vanda Pharmaceuticals
7.2.1 Vanda Pharmaceuticals Company Summary
7.2.2 Vanda Pharmaceuticals Business Overview
7.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Major Product Offerings
7.2.4 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue in Global Market (2019-2024)
7.2.5 Vanda Pharmaceuticals Key News & Latest Developments
7.3 Merck & Co., Inc.
7.3.1 Merck & Co., Inc. Company Summary
7.3.2 Merck & Co., Inc. Business Overview
7.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Major Product Offerings
7.3.4 Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue in Global Market (2019-2024)
7.3.5 Merck & Co., Inc. Key News & Latest Developments
7.4 Pfizer Inc.
7.4.1 Pfizer Inc. Company Summary
7.4.2 Pfizer Inc. Business Overview
7.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Major Product Offerings
7.4.4 Pfizer Inc. Insomnia Therapeutics Drugs Revenue in Global Market (2019-2024)
7.4.5 Pfizer Inc. Key News & Latest Developments
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Major Product Offerings
7.5.4 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue in Global Market (2019-2024)
7.5.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.6 Mylan N.V.
7.6.1 Mylan N.V. Company Summary
7.6.2 Mylan N.V. Business Overview
7.6.3 Mylan N.V. Insomnia Therapeutics Drugs Major Product Offerings
7.6.4 Mylan N.V. Insomnia Therapeutics Drugs Revenue in Global Market (2019-2024)
7.6.5 Mylan N.V. Key News & Latest Developments
7.7 Sumitomo Dainippon Pharma Co., Ltd
7.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Summary
7.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
7.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Major Product Offerings
7.7.4 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue in Global Market (2019-2024)
7.7.5 Sumitomo Dainippon Pharma Co., Ltd Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Insomnia Therapeutics Drugs Major Product Offerings
7.8.4 Sanofi Insomnia Therapeutics Drugs Revenue in Global Market (2019-2024)
7.8.5 Sanofi Key News & Latest Developments
7.9 Paratek Pharmaceuticals Inc.
7.9.1 Paratek Pharmaceuticals Inc. Company Summary
7.9.2 Paratek Pharmaceuticals Inc. Business Overview
7.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Major Product Offerings
7.9.4 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue in Global Market (2019-2024)
7.9.5 Paratek Pharmaceuticals Inc. Key News & Latest Developments
7.10 Ebb Therapeutics
7.10.1 Ebb Therapeutics Company Summary
7.10.2 Ebb Therapeutics Business Overview
7.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Major Product Offerings
7.10.4 Ebb Therapeutics Insomnia Therapeutics Drugs Revenue in Global Market (2019-2024)
7.10.5 Ebb Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Insomnia Therapeutics Drugs Market Opportunities & Trends in Global Market
Table 2. Insomnia Therapeutics Drugs Market Drivers in Global Market
Table 3. Insomnia Therapeutics Drugs Market Restraints in Global Market
Table 4. Key Players of Insomnia Therapeutics Drugs in Global Market
Table 5. Top Insomnia Therapeutics Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Insomnia Therapeutics Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Insomnia Therapeutics Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Insomnia Therapeutics Drugs Product Type
Table 9. List of Global Tier 1 Insomnia Therapeutics Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insomnia Therapeutics Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Insomnia Therapeutics Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Insomnia Therapeutics Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Insomnia Therapeutics Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Insomnia Therapeutics Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Insomnia Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Insomnia Therapeutics Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Takeda Pharmaceutical Company Ltd. Company Summary
Table 31. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Product Offerings
Table 32. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Takeda Pharmaceutical Company Ltd. Key News & Latest Developments
Table 34. Vanda Pharmaceuticals Company Summary
Table 35. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Product Offerings
Table 36. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Vanda Pharmaceuticals Key News & Latest Developments
Table 38. Merck & Co., Inc. Company Summary
Table 39. Merck & Co., Inc. Insomnia Therapeutics Drugs Product Offerings
Table 40. Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Merck & Co., Inc. Key News & Latest Developments
Table 42. Pfizer Inc. Company Summary
Table 43. Pfizer Inc. Insomnia Therapeutics Drugs Product Offerings
Table 44. Pfizer Inc. Insomnia Therapeutics Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Pfizer Inc. Key News & Latest Developments
Table 46. Teva Pharmaceutical Industries Ltd. Company Summary
Table 47. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Product Offerings
Table 48. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 50. Mylan N.V. Company Summary
Table 51. Mylan N.V. Insomnia Therapeutics Drugs Product Offerings
Table 52. Mylan N.V. Insomnia Therapeutics Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. Mylan N.V. Key News & Latest Developments
Table 54. Sumitomo Dainippon Pharma Co., Ltd Company Summary
Table 55. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Product Offerings
Table 56. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Sumitomo Dainippon Pharma Co., Ltd Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Insomnia Therapeutics Drugs Product Offerings
Table 60. Sanofi Insomnia Therapeutics Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. Sanofi Key News & Latest Developments
Table 62. Paratek Pharmaceuticals Inc. Company Summary
Table 63. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Product Offerings
Table 64. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue (US$, Mn) & (2019-2024)
Table 65. Paratek Pharmaceuticals Inc. Key News & Latest Developments
Table 66. Ebb Therapeutics Company Summary
Table 67. Ebb Therapeutics Insomnia Therapeutics Drugs Product Offerings
Table 68. Ebb Therapeutics Insomnia Therapeutics Drugs Revenue (US$, Mn) & (2019-2024)
Table 69. Ebb Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Insomnia Therapeutics Drugs Segment by Type in 2023
Figure 2. Insomnia Therapeutics Drugs Segment by Application in 2023
Figure 3. Global Insomnia Therapeutics Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Insomnia Therapeutics Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Insomnia Therapeutics Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Insomnia Therapeutics Drugs Revenue in 2023
Figure 8. By Type - Global Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 16. US Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 28. China Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Insomnia Therapeutics Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Insomnia Therapeutics Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Vanda Pharmaceuticals Insomnia Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Merck & Co., Inc. Insomnia Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Pfizer Inc. Insomnia Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Mylan N.V. Insomnia Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Sanofi Insomnia Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Ebb Therapeutics Insomnia Therapeutics Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
